![]() Washington Post | Safety fears halt Pfizer drug study The Australian - IN a surprising setback for the world's largest drugmaker Pfizer Inc halted development today of its top experimental medicine the cholesterol drug torcetrapib after safety concerns. Pfizer Ends Studies on Drug for Treating Heart Disease UPDATE 1-Pfizer ends development of key cholesterol drug |